These results were further confirmed by the TCGA database, which indicated that HCC patients with higher mRNA expression of NEIL3 had worse OS and DFS (Figure 2(c), P < 0.0001; Figure 2(d), P < 0.001). Here, NEIL3 is linked to hepatocellular carcinoma.